Senseonics Inc.

SENS | NASDAQ

Price Alert Chart Builder DCF Calculator

$9.89

+$0.11 (+1.12%)

Sep 22, 2026, 1:58 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.12%

(1D)

Rating

Updated: Aug 15, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $413.41M

1D Range

9.52 9.92

52W Range

4.79 11.58

Valuation (TTM)

PE -4.31

PB 4.53

EV/EBITDA -4.14

Valuation (NTM)

Forward PE N/A

Forward PEG 0.29

Price Target $13.75

Cash Flow

FCF Yield -31.6%

SBC Adj. FCF Yield -34.9%

SBC Impact -10.5%

Margins

Gross Margin 54.9%

Operating Margin -223.2%

FCF Margin -265.7%

Growth (CAGR)

Revenue 3Y | 5Y 38.0% | 35.1%

Dil EPS 3Y | 5Y 9.8% | -206.9%

FCF 3Y | 5Y -37.7% | -16.0%

Returns

ROA -61.9%

ROE -165.8%

ROIC -71.2%

Financial Health

Net Debt

$17.09M

Current Ratio 6.74

Interest Coverage -20.96

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions ...

Sector Healthcare

Industry Medical - Devices

Employees 130

IPO Date Dec 21, 2015

Website www.senseonics.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 4, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$14.50

Upside

+46.61%

Buy (4)

Hold (1)

Sell (0)

Analyst Details ➞